Literature DB >> 11397088

Selection, characterization and x-ray structure of anti-ampicillin single-chain Fv fragments from phage-displayed murine antibody libraries.

J Burmester1, S Spinelli, L Pugliese, A Krebber, A Honegger, S Jung, B Schimmele, C Cambillau, A Plückthun.   

Abstract

Single-chain Fv (scFv) antibody libraries were constructed from mice immunized with an ampicillin-bovine serum albumin conjugate. Several antibodies with specificity for intact ampicillin were selected by phage display and characterized. The antibody scFv fragment aL2 binds to intact ampicillin and shows no detectable cross-reactivity with hydrolyzed ampicillin. We determined the X-ray structures of two crystal forms of w.t. aL2, which differ mainly in the side-chain conformation of Trp H109 (according to a new consensus nomenclature Kabat residue number H95) in the extremely short (three residues) CDR H3 and the presence or absence of a well-resolved molecule of 2-methyl-pentane-2,4-diol in the bottom of the binding pocket. Attempts to co-crystallize aL2 with its antigen or to diffuse ampicillin into the wild-type aL2 crystals were unsuccessful, since crystal contacts obstruct the binding pocket. However, a mutant with two point mutations near the N terminus (Gln H6 replaced by Glu and Ala H10 (Kabat H9) replaced by Gly) crystallized in a form compatible with antigen-binding. Although the mutations affect the conformation of framework I, the conformations of the binding pocket of the uncomplexed wild-type aL2 and of the mutant complex were almost identical. The structure explains the specificity of the antibody for intact ampicillin and the degree of cross-reactivity of aL2 with a wide variety of ampicillin analogs. This antibody system will be very useful as a diagnostic reagent for antibiotics use and abuse, as a model for the effect of expression of antibiotic binding molecules in Escherichia coli, and for directed evolution towards high antibiotic resistance. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11397088     DOI: 10.1006/jmbi.2001.4663

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  8 in total

1.  Modeling the three-dimensional structures of an unbound single-chain variable fragment (scFv) and its hypothetical complex with a Corynespora cassiicola toxin, cassiicolin.

Authors:  Adeel Malik; Ahmad Firoz; Vivekanand Jha; Elumalai Sunderasan; Shandar Ahmad
Journal:  J Mol Model       Date:  2010-03-16       Impact factor: 1.810

2.  An anti-hapten camelid antibody reveals a cryptic binding site with significant energetic contributions from a nonhypervariable loop.

Authors:  Sean W Fanning; James R Horn
Journal:  Protein Sci       Date:  2011-05-23       Impact factor: 6.725

3.  A computerized protein-protein interaction modeling study of ampicillin antibody specificity in relation to biosensor development.

Authors:  Minghua Wang; Jianping Wang
Journal:  J Mol Model       Date:  2011-02-11       Impact factor: 1.810

4.  Specific fluorine labeling of the HyHEL10 antibody affects antigen binding and dynamics.

Authors:  Mauro Acchione; Yi-Chien Lee; Morgan E DeSantis; Claudia A Lipschultz; Alexander Wlodawer; Mi Li; Aranganathan Shanmuganathan; Richard L Walter; Sandra Smith-Gill; Joseph J Barchi
Journal:  Biochemistry       Date:  2012-07-16       Impact factor: 3.162

5.  Chronic intranasal treatment with an anti-Aβ(30-42) scFv antibody ameliorates amyloid pathology in a transgenic mouse model of Alzheimer's disease.

Authors:  Susann Cattepoel; Michael Hanenberg; Luka Kulic; Roger M Nitsch
Journal:  PLoS One       Date:  2011-04-05       Impact factor: 3.240

6.  Structure basis of neutralization by a novel site II/IV antibody against respiratory syncytial virus fusion protein.

Authors:  Qingqing Xie; Zhao Wang; Fengyun Ni; Xiaorui Chen; Jianpeng Ma; Nita Patel; Hanxin Lu; Ye Liu; Jing-Hui Tian; David Flyer; Michael J Massare; Larry Ellingsworth; Gregory Glenn; Gale Smith; Qinghua Wang
Journal:  PLoS One       Date:  2019-02-07       Impact factor: 3.240

7.  A novel strategy for efficient production of anti-V3 human scFvs against HIV-1 clade C.

Authors:  Rajesh Kumar; Raiees Andrabi; Ashutosh Tiwari; Somi Sankaran Prakash; Naveet Wig; Durgashree Dutta; Anurag Sankhyan; Lubina Khan; Subrata Sinha; Kalpana Luthra
Journal:  BMC Biotechnol       Date:  2012-11-15       Impact factor: 2.563

8.  The POM monoclonals: a comprehensive set of antibodies to non-overlapping prion protein epitopes.

Authors:  Magdalini Polymenidou; Rita Moos; Mike Scott; Christina Sigurdson; Yong-Zhong Shi; Bill Yajima; Iva Hafner-Bratkovic; Roman Jerala; Simone Hornemann; Kurt Wuthrich; Anne Bellon; Martin Vey; Graciela Garen; Michael N G James; Nat Kav; Adriano Aguzzi
Journal:  PLoS One       Date:  2008-12-08       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.